Browsing Tag
bluebird bio
3 posts
PepGen brings in gene therapy veteran to accelerate breakthrough neuromuscular treatments
PepGen names gene therapy veteran Kasra Kasraian as CTO to scale up oligonucleotide therapies for neuromuscular diseases. Find out what this means for investors.
bluebird bio unveils US commercial strategy for LYFGENIA gene therapy
bluebird bio, Inc., a pioneer in the biotechnology industry, has announced the U.S. commercial infrastructure for LYFGENIA (lovotibeglogene…
BMS, bluebird bio bag Abecma FDA approval for multiple myeloma in adults
Abecma FDA approval : Bristol Myers Squibb (BMS) and bluebird bio have secured approval from the US Food…